{'fraction_non_alphanumeric': 0.02654867256637168, 'fraction_numerical': 0.007866273352999017, 'mean_word_length': 4.988235294117647, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
New tools ready for Chlamydia diagnosis, treatment, but teens need education most.

ABSTRACT TWO SIGNIFICANT advances in the diagnosis and treatment of Chlamydia trachomatis infection are or will soon be available to physicians, as well as screening guidelines from the Centers for Disease Control and Prevention (CDC). Chlamydia infection accounts for the bulk of the sexually transmitted disease (STD) epidemic in the United States—4 million new cases are expected this year (Figure), and an estimated 50000 women will be rendered sterile by the disease.For the first time, physicians will be able to use a noninvasive test on men. The test is so sensitive it can detect traces of Chlamydia DNA in urine. And in the treatment realm, a single, 1-g oral dose of azithromycin will suffice—expensive (costing patients almost four times as much as a 1-week regimen of doxycycline) but worth it in noncompliant patients who might otherwise continue to infect their partners, public health experts say."The ability to do a